UNAIDS’ targets are for 90% of people with HIV to be diagnosed, 90% of diagnosed people to be taking treatment, and 90% of people on treatment to have an undetectable viral load. Achieving these targets will greatly reduce the spread of HIV.

Achieving the 90-90-90 target: latest news

Achieving the 90-90-90 target features

Achieving the 90-90-90 target news from aidsmap

More news

Achieving the 90-90-90 target news selected from other sources

  • US: 80% of new HIV cases transmitted by undiagnosed or untreated people

    In 2016, more than 80% of new HIV infections in the United States were transmitted by individuals who either did not know they were infected with HIV or had been diagnosed but were not receiving care, according to data released on the first day of the National HIV Prevention Conference in Atlanta.

    19 March 2019 | Healio
  • South Africa: The problem of stopping or not starting HIV treatment

    South Africa has the largest HIV epidemic in the world. The United Nations Programme on HIV/AIDS (UNAIDS) estimates that there are approximately 7.2-million South Africans living with HIV, with 270 000 new HIV infections in 2017. South Africa also has the largest antiretroviral therapy (ART) programme with more than four million people estimated to be on treatment. Despite progress in getting people onto treatment, recent evidence indicates that the country is still experiencing significant numbers of people developing and dying from advanced HIV-disease. This is as result of people who either do not start treatment, start treatment late, or stop and re-start treatment. There is, therefore, an urgent need to not only prioritise HIV-testing but to ensure that once people start treatment, they remain on life-long care.

    12 March 2019 | Spotlight
  • Wider ART Rollout Tied to Declines in HIV Mortality in Kenya

    Both all-cause mortality and mortality among HIV-positive people dropped in Western Kenya following a scale-up of antiretroviral therapy (ART), a researcher said here. From 2011 to 2016, all-cause mortality dropped from 10.0 per 1,000 person years (95% CI 8.4-11.7) to 7.5 per 1,000 person years (95% CI 5.8-9.1), reported Emily C. Zielinski-Gutierrez, DrPH, of the CDC.

    12 March 2019 | MedPage Today
  • Largest ever HIV prevention study delivers sobering message

    The recipe for ending HIV epidemics seems straightforward. Introduce widespread testing. Immediately put those who test positive on antiretroviral (ARV) drugs, which suppress the virus to undetectable levels so those people won’t infect others. The number of new infections will drop, and the epidemic will peter out. But massive, costly studies done in the past few years have failed to show this strategy can reliably curb the spread of the virus, to the frustration of researchers.

    12 March 2019 | Science
  • The Aids endgame: how the UK and US are committed to wiping out HIV

    Governments on both sides of the Atlantic are now so confident that they have the virus under control they have both predicted that they can stop the disease in its tracks.

    07 March 2019 | Daily Telegraph
  • CROI 2019: Thailand’s strides spanned HIV treatment, prevention and research

    he first HIV vaccine trials to yield signs of hope happened here. Thailand was also the first Asian country to eliminate mother-to-child transmission of HIV. Now, Thailand has achieved the first part of UNAIDS’ 90-90-90 targets: 98 percent of people infected with HIV know their status.

    06 March 2019 | Science Speaks
  • Hancock’s goal of no new HIV cases by 2030 is a pipe dream without NHS funding

    England will see no new cases of HIV by 2030 according to a pledge made by the Matt Hancock, Secretary of State for Health and Social Care, in January. Whilst Mr Hancock’s comments may suggest that the UK government is working towards a reduction in the number of people being newly diagnosed with the virus, it is clear that many working within the HIV sector have their reservations.

    06 March 2019 | Euronews
  • 'Test and Treat' reduces new HIV infections by a third in African communities

    New HIV infections in southern Africa could be reduced substantially by offering entire communities voluntary HIV testing, and immediately referring those who test positive for HIV treatment in line with local guidelines, according to new research presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, USA today.

    05 March 2019 | Imperial College London
  • San Francisco Is Beating H.I.V. Why Can’t Houston?

    We know how to fight the epidemic, but patients in the South still aren’t getting the treatment they need.

    04 March 2019 | The New York Times
  • Trump Plan To Beat HIV Hits Rough Road In Rural America

    Health officials and doctors treating patients with HIV in predominantly rural states say any extra funding would be welcome. But they say strategies that work in progressive cities like Seattle won’t necessarily work in rural areas of Alabama, Arkansas, Kentucky, Mississippi, Missouri, Oklahoma and South Carolina.

    24 February 2019 | Kaiser Health News
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.